The Intra-Individual Variability of Faecal Calprotectin: A Prospective Study In Patients With Active Ulcerative Colitis

被引:171
|
作者
Lasson, Anders [1 ]
Stotzer, Per-Ove [2 ]
Ohman, Lena [2 ,3 ]
Isaksson, Stefan [2 ,3 ]
Sapnara, Maria [3 ]
Strid, Hans [2 ]
机构
[1] Sodra Alvsborgs Hosp, Dept Internal Med, S-40182 Boras, Sweden
[2] Sahlgrens Univ Hosp, Dept Internal Med, Gothenburg, Sweden
[3] Univ Gothenburg, Sahlgrenska Acad, Dept Biomed, Gothenburg, Sweden
来源
JOURNAL OF CROHNS & COLITIS | 2015年 / 9卷 / 01期
关键词
Ulcerative colitis; Calprotectin; Disease activity; INFLAMMATORY-BOWEL-DISEASE; GRANULOCYTE MARKER PROTEIN; EVIDENCE-BASED CONSENSUS; CROHNS-DISEASE; INTESTINAL INFLAMMATION; 5-AMINOSALICYLIC ACID; SURROGATE MARKERS; BLOOD LEUKOCYTES; ACTIVITY INDEX; DEFINITIONS;
D O I
10.1016/j.crohns.2014.06.002
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and aims: Leukocyte-derived proteins in faeces, especially calprotectin, are increasingly used to assess disease activity in ulcerative colitis. The objectives of the present study were to assess the importance of factors related to the stool sampling procedure. Methods: For 2 days, patients with active ulcerative colitis collected two stool samples at each bowel movement. The time of defecation, consistency and presence of blood were self-recorded in a diary. The variability in the concentrations of calprotectin during the day and between two consecutive days was assessed, as was the stability of calprotectin concentrations in samples stored at room temperature. Results: Altogether, 18 patients collected 287 stool samples. The intraclass correlation coefficient in pairs of samples from 132 bowel movements was 0.79 (95% CI 0.48-0.90). The median individual coefficient of variation in samples collected during the same day was 52% (4-178). There was a correlation between the level of calprotectin and the time between bowel movements (r = 0.5; p = 0.013). After 3 days at room temperature the calprotectin concentrations in stool samples were unchanged, but after 7 days a significant (p < 0.01) decrease was found (mean 28%; 95% CI 0.10-0.47). Conclusion: The present data reveal a great variability in the concentrations of calprotectin in stool samples collected during a single day. Since the levels of calprotectin increased with longer time between the bowel movements, it seems most appropriate to analyse stool from the first bowel movement in the morning. Moreover, storage of stool samples at room temperature for more than 3 days is not advisable.
引用
下载
收藏
页码:26 / 32
页数:7
相关论文
共 50 条
  • [1] A Prospective Single Centre Evaluation of the Intra-Individual Variability of Faecal Calprotectin in Quiescent Crohn's Disease Patients
    Smith, Lyn A.
    Naismith, Graham
    Munro, Joanna I.
    Rankin, Karen
    Barry, Sarah
    Morris, Allan J.
    Winter, Jack W.
    Gaya, Daniel R.
    GASTROENTEROLOGY, 2012, 142 (05) : S660 - S660
  • [2] A PROSPECTIVE SINGLE CENTRE EVALUATION OF THE INTRA-INDIVIDUAL VARIABILITY OF FAECAL CALPROTECTIN IN QUIESCENT CROHN'S DISEASE PATIENTS
    Smith, L. A.
    Naismith, G.
    Barry, S.
    Munro, J.
    Rankin, K.
    Winter, J.
    Morris, A. J.
    Gaya, D.
    GUT, 2012, 61 : A227 - A228
  • [3] A prospective single-centre evaluation of the intra-individual variability of faecal calprotectin in quiescent Crohn's disease
    Naismith, G. D.
    Smith, L. A.
    Barry, S. J. E.
    Munro, J. I.
    Laird, S.
    Rankin, K.
    Morris, A. J.
    Winter, J. W.
    Gaya, D. R.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2013, 37 (06) : 613 - 621
  • [4] The intra-individual Variability of Fecal Calprotectin in patients with GI-symptoms
    Netzer, Seraina
    Behrouz, Saied
    Mehr-Rahimi, Siamak
    Moriconi, Federico
    Wilhelmi, Martin
    Netzer, Peter
    SWISS MEDICAL WEEKLY, 2019, : 2S - 2S
  • [5] The intra-individual Variability of Fecal Calprotectin in healthy individuals
    Netzer, Seraina
    Netzer, Peter
    SWISS MEDICAL WEEKLY, 2019, : 15S - 15S
  • [6] Clinical importance of faecal calprotectin variability in inflammatory bowel disease: intra-individual variability and standardisation of sampling procedure
    Kristensen, Vendel
    Malmstrom, Gunn Helen
    Skar, Viggo
    Roseth, Arne
    Moum, Bjorn
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2016, 51 (05) : 548 - 555
  • [7] Clinical application of faecal calprotectin in ulcerative colitis patients
    Scaioli, Eleonora
    Scagliarini, Michele
    Cardamone, Carla
    Liverani, Elisa
    Ugolini, Giampaolo
    Festi, Davide
    Bazzoli, Franco
    Belluzzi, Andrea
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2015, 27 (12) : 1418 - 1424
  • [8] Faecal calprotectin correlates well with extent of active endoscopic inflammation in patients with ulcerative colitis
    Chayut, D.
    Kaplan, M.
    Chowers, Y.
    Waterman, M.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S273 - S273
  • [9] Faecal calprotectin in the diagnosis of ulcerative colitis among Egyptian patients
    Sharaf-Eldin, M.
    Iman, H.
    Nasser, M.
    Tabak, S.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 : 109 - 110
  • [10] The value of faecal calprotectin for assessing endoscopic activity and predicting future clinical course in patients with active ulcerative colitis treated with granulomonocytapheresis: a prospective study
    Shimoyama, T.
    Yamamoto, T.
    Umegae, S.
    Matsumoto, K.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S286 - S287